Ceftobiprole
| CAS No. | 209467-52-7 | Cat. No. | BCP18210 |
| Name | Ceftobiprole | ||
| Synonyms | BAL 9141; Ro 63-9141; Ro 63 9141; Ro 639141; BAL-9141; BAL9141; | ||
| Formula | C20H22N8O6S2 | M. Wt | 534.57 |
| Description | Ceftobiprole is a cephalosporin prodrug. It is used for the treatment of complicated skin and skin-structure infections (cSSSIs) due to methicillin-resistant Staphylococcus aureus (MRSA) and hospital-acquired pneumonia (HAP). Ceftobiprole is designed to bind the penicillin-resistant targets in Gram-positive bacteria, resulting in potent bactericidal activity against methicillin-resistant MRSA and penicillin-resistant Streptococcus pneumoniae (PRSP). | ||
| Pathways | Microbiology/Virology | ||
| Targets | Antibiotic | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.